过敏性鼻炎和其他与泰国喘控制相关的并发病
Thitiwat Sriprasart1, Narongkorn Saiphoklang2, Theerasuk Kawamatawong3
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Frontiers in medicine
|January 26, 2024
概括
过敏性鼻炎 (AR) 在泰国喘患者中很常见,并影响喘控制,生活质量和肺功能. 管理AR对于改善喘结果和患者福祉至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 过敏学 过敏学
- 临床医学 临床医学
背景情况:
- 喘和过敏性鼻炎 (AR) 经常同时存在,导致患者严重残疾.
- 了解AR和喘控制之间的相互作用对于有效管理至关重要.
研究的目的:
- 为了研究过敏性鼻炎 (AR) 和喘控制之间的关联.
- 评估AR对成人喘患者喘相关生活质量和并发症的影响.
主要方法:
- 一项涉及泰国682名成人喘患者的横截面研究.
- 使用喘控制测试 (ACT) 评估喘控制,并通过视觉模拟量表 (VAS) 评估AR严重程度.
- 收集有关喘相关生活质量 (AQLQ),并发症和总IgE水平的数据.
主要成果:
- 在研究人群中观察到AR的高患病率 (86.1%).
- 严重的AR与喘控制较差 (ACT得分),生活质量降低 (AQLQ) 和肺功能下降 (FEV1/FVC) 有显著的关联.
- 患有失控喘的患者表现出更高的并发症负担.
结论:
- 过敏性鼻炎在泰国喘患者中非常普遍,并显著影响喘控制和生活质量.
- 复发性肺炎的严重程度与喘控制和肺功能减弱相关.
- 综合性管理策略对于喘患者具有共存的AR至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298


